Truist Financial’s BioTelemetry, Inc. BEAT Stock Holding History

Truist Financial’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-180,453	Closed	-$13M	–	2789
2020 Q4	$13M	Sell	180,453 -130,937	-42%	-$6.85M	0.02%	529
2020 Q3	$14.2M	Buy	311,390 +1,232	+0.4%	+$51.5K	0.03%	451
2020 Q2	$14M	Sell	310,158 -58,671	-16%	-$2.63M	0.03%	447
2020 Q1	$14.2M	Buy	368,829 +176	+0%	+$8.1K	0.04%	410
2019 Q4	$17.1M	Buy	+368,653	New	+$16M	0.03%	450

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Truist Financial's BEAT Position: Q1 2021 in Review

Truist Financial sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 180,453 shares — an estimated $13M sold.

Truist Financial first reported a position in BEAT in Q4 2019 and held it in 5 quarters. The position peaked at $17.1M in Q4 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Truist Financial reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Truist Financial sold 180,453 BioTelemetry, Inc. shares in Q1 2021, an estimated $13M.
Truist Financial first reported a position in BioTelemetry, Inc. in Q4 2019 and held it in 5 quarters.
Truist Financial's BioTelemetry, Inc. position peaked at $17.1M in Q4 2019.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Truist Financial's 13F filing for Q1 2021, filed 17 May 2021.